11 completed, 4 recruiting, 2 not yet recruiting, 1 terminated. 9 Not applicable, 3 Phase 1, 3 Phase 4, 2 Early Phase 1, 1 Phase 2.
Follow Hyperglycaemia (Diabetic): new trials by email Literature Review of Hyperglycaemia (Diabetic) trials Research Report on Hyperglycaemia (Diabetic)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The BRIGHT Study (Device Name: HALO System) The HALO System - Diabetes Mellitus - Type 1, Diabetes Mellitus - Type 2 | Not applicable | Not yet recruiting | Indigo Diabetes NV | 12 | 2026-12-01 | 2026-08-04 |
| Validation of Remote Photoplethysmography for Non-Invasive Estimation of Blood Glucose and HbA1c Diabetes Mellitus, Hyperglycaemia (Diabetic) | Not yet recruiting | Tarumanagara University | 300 | 2026-03-23 | 2026-04-20 | |
| New Taipei City 888 Digital Medical AI Platform for Prevention and Care of the Three Highs and Cardio-Renal-Vascular Diseases Interactive digital modules, Antihypertensive Medication Management - Microalbuminuria, Microalbuminuria /Creatinine Ratios ACR | Not applicable | Recruiting | New Taipei City Medical Association | 4162 | 2026-02-05 | 2026-05-14 |
| Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes Arginine hydrochloride, Sodium Chloride 0.9% - Diabetes (DM), Diabetic Ketoacidosis | Phase 1 / Phase 2 | Recruiting | David K Carroll | 60 | 2025-12-19 | 2026-02-12 |
| Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant Anti-VEGF treatment, Dexamethasone implant, Treatment with intravitreal anti-VEGF OR Dexamethasone implant - Diabetic Macular Edema, Visual Impairment | Not applicable | Recruiting | Vastra Gotaland Region | 150 | 2025-08-01 | 2025-11-21 |
| Impact of High-Oleic Palm Oil Consumption on Cardiovascular Biomarkers in Adults in Bogotá High-oleic palm oil - Insulinemic Response, Type 2 Diabetes (Adult Onset) | Not applicable | Completed | Ruby Alejandra Villamil | 52 | 2024-10-22 | 2026-08-05 |
| Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM glucose, moxifloxacin - Diabetes Type 2, Hyperglycaemia (Diabetic) | Not applicable | Terminated | Richmond Pharmacology Limited | 14 | 2023-04-13 | 2026-07-01 |
| To Assess the Prevalence, Management Practices, and Clinical Outcomes Associated With Hyperglycemia Among Hospitalized Patients, With a Particular Focus on the Interplay Between Metabolic Biomarkers, Nutritional Status, and Body Composition Diabete Mellitus, Diabete Type 2 | Completed | Medanta, The Medicity, India | 362 | 2023-01-01 | 2026-06-04 | |
| The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects The SHINE SYSTEM - Diabetes Mellitus, Diabetes Mellitus, Type 1 | Not applicable | Completed | Indigo Diabetes NV | 6 | 2022-09-21 | 2024-03-15 |
| Perioperative Evaluation of Glucose Profile Using Continuous Glucose Monitoring System in Glucose Intolerant Patients carbohydrate supplement (Preload™), 6 hours of preoperative fasting - Hyperglycaemia (Diabetic), Bariatric Surgery Candidate | Not applicable | Withdrawn | University Hospital, Lille | 2022-09-01 | 2026-05-22 | |
| The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Patients Low dose omega-3 fatty acid supplementation, High dose omega-3 fatty acid supplementation, Control drug - Hyperglycaemia (Diabetic), Hyperlipidemias | Not applicable | Completed | Zhejiang University | 415 | 2020-10-10 | 2024-07-12 |
| Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) Liraglutide, insulin glargine - Type 2 Diabetes Patients, Overweight and Obesity | Phase 4 | Recruiting | The First Affiliated Hospital of Xiamen University | 164 | 2019-01-10 | 2025-01-13 |
| Hypoglycaemia and Cardiac Arrhythmias in Type 1 Diabetes Hypoglycemia (Diabetic), Hyperglycaemia (Diabetic) | Completed | Steno Diabetes Center Copenhagen | 30 | 2018-12-01 | 2022-01-18 | |
| Peripheral Nerve Blocks for Above-the-knee Amputations Peripheral nerve block, Intravenous Sedatives, Lateral femoral cutaneous nerve blocks - Peripheral Vascular Diseases, Hyperglycaemia (Diabetic) | Phase 4 | Completed | University of Florida | 30 | 2018-02-09 | 2026-01-08 |
| Investigating the Role of the Polyol Pathway in the Central Nervous System Production of Fructose Insulin, exercise, Dietary counseling - Hyperglycaemia (Diabetic) | Early Phase 1 | Completed | Yale University | 8 | 2018-01-18 | 2024-02-05 |
| Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus Globalagliatin Hydrochloride, Placebo - Hyperglycaemia (Diabetic), Type 2 Diabetes Mellitus | Phase 1 | Completed | Yabao Pharmaceutical Group | 24 | 2018-01-03 | 2020-01-03 |
| Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes Dichloroacetate, Placebo oral capsule - Hyperglycaemia (Diabetic) | Early Phase 1 | Completed | Yale University | 21 | 2017-11-30 | 2021-01-22 |
| Insulin Therapy for Postreperfusion Hyperglycemia Insulin - Hyperglycaemia (Diabetic), Liver Transplantation | Phase 4 | Unknown | Seoul National University Hospital | 20 | 2017-05-15 | 2024-04-19 |
| The Assessment of Single-Dose Safety,Tolerability, Pharmacokinetics and Pharmacodynamic of Globalagliatin Hydrochloride globalagliatin hydrochloride, placebo - Hyperglycaemia (Diabetic), Healthy Volunteers | Phase 1 | Completed | Yabao Pharmaceutical Group | 44 | 2017-04-05 | 2018-01-31 |
| Microclinic Social Network Behavioral Health Trial in Jordan Microclinic Behavioral Health Full Program (education curriculum in classroom setting, plus full social interaction program), Microclinic Behavioral Health Basic Program (education-only in classroom setting; no structured social interactions) - Diabetes Mellitus, Type 2, Obesity | Not applicable | Completed | Microclinic International | 914 | 2012-01-01 | 2024-02-01 |
Hyperglycemia (20) · Diabetes Mellitus (9) · Diabetes Mellitus, Type 2 (8) · Diabetes Mellitus, Type 1 (4) · Hypoglycemia (4) · Diabetic Ketoacidosis (3) · Hyperlipidemias (3) · Hypertension (3) · Obesity (3) · Arrhythmias, Cardiac (1) · Body Weight (1) · Body Weight Changes (1) · Body-Weight Trajectory (1) · Coronary Artery Disease (1) · Dyslipidemias (1)
Glucose Metabolism Disorders (20) · Metabolic Diseases (20) · Nutritional and Metabolic Diseases (20) · Endocrine System Diseases (14) · Pathological Conditions, Signs and Symptoms (7) · Cardiovascular Diseases (5) · Diabetes Mellitus (5) · Autoimmune Diseases (4) · Immune System Diseases (4) · Signs and Symptoms (4) · Acid-Base Imbalance (3) · Acidosis (3) · Diabetes Complications (3) · Heart Diseases (3) · Lipid Metabolism Disorders (3)
Insulin (2) · Arginine (1) · Dexamethasone (1) · Dexmedetomidine (1) · Dichloroacetic Acid (1) · Drug and Narcotic Control (1) · Exercise (1) · Glucose (1) · Insulin Glargine (1) · Liraglutide (1) · Moxifloxacin (1) · Nutrition Assessment (1) · Propofol (1) · Saline Solution (1) · Sodium Chloride (1)
Indigo Diabetes NV (2) · Yabao Pharmaceutical Group (2) · Yale University (2) · David K Carroll (1) · Medanta, The Medicity, India (1) · Microclinic International (1) · New Taipei City Medical Association (1) · Richmond Pharmacology Limited (1) · Ruby Alejandra Villamil (1) · Seoul National University Hospital (1) · Steno Diabetes Center Copenhagen (1) · Tarumanagara University (1) · The First Affiliated Hospital of Xiamen University (1) · University Hospital, Lille (1) · University of Florida (1)
China (4) · United States (4) · Belgium (1) · Colombia (1) · Denmark (1) · France (1) · India (1) · Indonesia (1) · Jordan (1) · Slovenia (1) · South Korea (1) · Sweden (1) · Taiwan (1) · United Kingdom (1)
Lei Yang (2) · Alexander Halim Santoso (1) · Christophe De Block, Prof. Dr. (1) · Christophe De Block, Prof. dr. (1) · Chul-Woo Jung, MD, PhD (1) · Daniel E Zoughbie, D.Phil. (1) · David Wongso (1) · Eric L Ding, Sc.D. (1) · Ernawati Ernawati (1) · Janice Hwang, MD (1) · Jaydee Kirani Wong (1) · Kieren Nathan Wong (1) · Meiske Yunithree Suparman (1)
PMID 33125674, PMID 35093240, PMID 35247067, PMID 38507441, PMID 40347940, PMID 41559698
K23DK109284 (1)